This year’s American Society of Hematology (ASH) annual meeting will be held between December 9 and 12, in Orlando, Florida. We expect this year’s meeting to be relatively quiet with the majority of presentations being updated data from ongoing studies or studies providing incremental supportive data.

In the PDF linked at the top of this page is a list of trial data that BioMedTracker will be covering at this year’s meeting. We have listed the drug, indication and abstract title. Please note that the abstracts summarizing the trial data presented at ASH are available for review at the ASH website. We are prohibited from analyzing data until the actual presentations are made at ASH.

For our disclosures, please read the BioMedTracker Research Standards.